Skip to main content
Rossari Biotech Limited (NSE:ROSSARI)
India flag India · Delayed Price · Currency is INR
467.00
-1.95 (-0.42%)
Apr 29, 2026, 3:30 PM IST

Rossari Biotech Revenue

In the fiscal year ending March 31, 2026, Rossari Biotech had annual revenue of 24.19B INR with 16.27% growth. Rossari Biotech had revenue of 7.04B in the quarter ending March 31, 2026, with 21.46% growth.

Revenue
24.19B
Revenue Growth
+16.27%
P/S Ratio
1.07
Revenue / Employee
45.21M
Employees
535
Market Cap
25.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202624.19B3.38B16.27%
Mar 31, 202520.80B2.50B13.64%
Mar 31, 202418.31B1.75B10.55%
Mar 31, 202316.56B1.73B11.66%
Mar 31, 202214.83B7.74B109.06%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jubilant Agri and Consumer Products 18.04B
Savita Oil Technologies 41.44B
Fineotex Chemical 5.78B
Sirca Paints India 4.59B
Veedol Corporation 20.94B
NOCIL 13.12B
Tatva Chintan Pharma Chem 4.80B
Jai Corp 6.63B
Revenue Rankings

Rossari Biotech News

More News